STOCK TITAN

Oaktree Acquisition III Life Sciences Unit (OACCU) Stock Price, News & Analysis

OACCU NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
0 25 sessions, October 13, 2025 to October 22, 2026
Largest daily move
-3.4% close of October 27, 2025
1-year change
-2.4% closing prices, October 13, 2025 to October 22, 2026

Company Description

Oaktree Acquisition III Life Sciences Unit (NASDAQ: OACCU) is classified in the shell companies industry within the Financial Services sector.

OACCU has declined 2.4% over the past year. The last closing price was $10.80.

For FY2025, Oaktree Acquisition III Life Sciences Unit reported net income of $7.3M.

This page collects what Stock Titan holds for OACCU, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

$10.80
-
-
Last updated: October 22, 2026 at 13:52
-2.4%
Performance 1 year

Oaktree Acquisition III Life Sciences Unit (OACCU) closed at $10.80 on October 22, 2026. Over the past 12 months, the price has lost 2.4%.

See what a $1,000 investment in OACCU would be worth today

Average down calculator for OACCU

OACCU Metrics & Rankings

Price returns through October 22, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Financial Highlights

operating income reached -$1.2M, and net income was $7.3M. The company generated -$422K in operating cash flow. The current ratio was 1.19, measuring current assets divided by current liabilities.

$7.3M
Net Income (FY2025)
-$422K
Operating Cash Flow
—
Revenue (FY2025)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Oaktree Acquisition III Life Sciences Unit (OACCU) currently stands at 1.9 thousand shares, down 0.3% from the previous reporting period. Since October 2025, short interest has decreased by 44.6%.

Days to Cover History

Last 12 Months

Days to cover for Oaktree Acquisition III Life Sciences Unit (OACCU) currently stands at 971.5 days, up 99.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 1672.8%. Across the settlements charted above, it has ranged from 1.8 to 1000.0 days.

OACCU Company Profile & Sector Positioning

Oaktree Acquisition III Life Sciences Unit (OACCU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.

Investors comparing OACCU often look at related companies in the same sector, including Aimei Health Technology Co., Ltd Unit (AFJKU), Aldel Financial II Inc. Units (ALDFU), Bayview Acquisition Corp Unit (BAYAU), Cayson Acquisition Corp Unit (CAPNU), and Future Vision II Acquisition Corporation Units (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OACCU's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Oaktree Acquisition III Life Sciences Unit (OACCU)?

The current stock price of Oaktree Acquisition III Life Sciences Unit (OACCU) is $10.80 as of October 22, 2026.

What is the net income of Oaktree Acquisition III Life Sciences Unit (OACCU)?

The FY2025 net income of Oaktree Acquisition III Life Sciences Unit (OACCU) is $7.3M, from its most recent completed fiscal year.

What is the operating cash flow of Oaktree Acquisition III Life Sciences Unit (OACCU)?

The operating cash flow of Oaktree Acquisition III Life Sciences Unit (OACCU) is -$422K for FY2025, its most recent completed fiscal year. Learn about cash flow.

What is the current ratio of Oaktree Acquisition III Life Sciences Unit (OACCU)?

The current ratio of Oaktree Acquisition III Life Sciences Unit (OACCU), current assets divided by current liabilities, was 1.19 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

What is the operating income of Oaktree Acquisition III Life Sciences Unit (OACCU)?

The operating income of Oaktree Acquisition III Life Sciences Unit (OACCU) is -$1.2M for FY2025, its most recent completed fiscal year. Learn about operating income.